COVID-19 in older adults: Clinical, psychosocial, and public health considerations

JCI Insight

Volumn 5, Issue 10, 2020, Pages

  Mills, John P ^a   Kaye, Keith S ^a   Mody, Lona ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIPYRETIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; REMDESIVIR; RNA DIRECTED RNA POLYMERASE INHIBITOR; TOCILIZUMAB;

ACUTE DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; AGING; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASSISTED LIVING FACILITY; BODY TEMPERATURE MEASUREMENT; CARDIOVASCULAR DISEASE; CAREGIVER; CASE FATALITY RATE; CHILL; CHINA; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMMUNITY DWELLING PERSON; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; COUGHING; CRITICALLY ILL PATIENT; DEMOGRAPHY; DIABETES MELLITUS; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EMERGENCY CARE; EPIDEMIC; FATIGUE; FEVER; GENERAL PRACTITIONER; GOVERNMENT; GROUND GLASS OPACITY; HEADACHE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROMOTION; HEALTH WORKFORCE; HIGH RISK POPULATION; HOME CARE; HOME ENVIRONMENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCUBATION TIME; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; ITALY; KOREA; LABORATORY TEST; LIFE SUSTAINING TREATMENT; LONG TERM CARE; LUNG DISEASE; LUNG INFILTRATE; LYMPHOCYTOPENIA; MEDICAL LEAVE; MEDICAL SOCIETY; MYALGIA; NOSE OBSTRUCTION; NURSE MANAGER; NURSE PRACTITIONER; NURSING HOME; OCCUPATIONAL EXPOSURE; OXYGEN THERAPY; PALLIATIVE THERAPY; PANDEMIC; PATHOPHYSIOLOGY; PATIENT ISOLATION; PATIENT SELECTION; PHYSICAL ACTIVITY; PHYSICIAN ASSISTANT; PROTEIN BINDING; PROTEIN EXPRESSION; PSYCHOLOGICAL WELL-BEING; PUBLIC HEALTH SERVICE; PUBLIC POLICY; REHABILITATION CENTER; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX DIFFERENCE; SMOKING; SOCIAL DISTANCE; SOCIAL PSYCHOLOGY; SOCIAL WORKER; SORE THROAT; TELEHEALTH; THERAPY EFFECT; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME; UNITED STATES; VIDEOCONFERENCING; VIRTUAL REALITY; VIRUS TRANSMISSION; VIRUS VIRULENCE; VULNERABLE POPULATION; AGE; AGED; BETACORONAVIRUS; CORONAVIRUS INFECTION; FEMALE; MALE; MORTALITY; PSYCHOLOGY; PUBLIC HEALTH; VERY ELDERLY; VIRUS PNEUMONIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; HEALTH POLICY; HOSPITALIZATION; HUMANS; MALE; PANDEMICS; PNEUMONIA, VIRAL; PUBLIC HEALTH;

EID: 85083865654     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/JCI.INSIGHT.139292     Document Type: Article

References (21)

1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry R F. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450-452.
2. [No authors listed]. COVID-19 Case Tracker. Johns Hopkins University and Medicine Coronavirus Resource Center. https://coronavirus.jhu.edu/. Accessed May 1, 2020.
3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242.
4. CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382-386.
5. Guan WJ, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
6. Dudley JP, Lee NT. Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clin Infect Dis. 2020:ciaa354.
7. Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581.
8. Lian J, et al. Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan. Clin Infect Dis. 2020:ciaa242.
9. Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
10. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.
11. Kimball A, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):377-381.
12. Lauer SA, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application [published ahead of print March 10, 2020]. Ann Intern Med. https://doi.org/10.7326/M20-0504.
13. Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [published ahead of print April 10, 2020]. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.013.
14. McMichael TM, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington [published ahead of print March 10, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2005412.
15. Bhimraj A, et al. Infectious Disease Society of America guidelines on the treatment and management of patients with COVID-19. Infectious Diseases Society of America. https://www.idsociety.org/COVID19guidelines. Published April 11, 2020. Accessed May 1, 2020.
16. Fang L, Karakiulakis G, Roth M. Are patients with hypertension diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):E21.
17. [No authors listed]. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. American Heart Association. https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician. Published March 17, 2020. Accessed May 1, 2020.
18. Grabowski DC, Joynt Maddox KE. Postacute care preparedness for COVID-19: thinking ahead [published ahead of print March 25, 2020]. JAMA. https://doi.org/10.1001/jama.2020.4686.
19. Emanuel EJ, et al. Fair allocation of scarce medical resources in the time of COVID-19 [published ahead of print March 23, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMsb2005114.
20. Hansen RJ, Talmage CA, Thaxton SP, Knopf RC. Barriers to age-friendly universities (AFU): Lessons from Osher Lifelong Learning Institute demographics and perceptions. Gerontol Geriatr Educ. 2019;40(2):221-243.
21. [No authors listed]. Preparedness checklist for nursing homes and other long-term care settings. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/long-term-care-checklist.html. Accessed May 1, 2020.